Lykos Therapeutics is currently working out ways to fund an additional Phase III study for its MDMA-assisted PTSD therapy ...
Medpage Today on MSN5d
Top FDA Official Exits; SCOTUS Takes Up Obamacare Case; Texas Doc SuspendedHere's what FDA found during an inspection at the Colorado facility linked to an E. coli outbreak at McDonald's: wet and ...
During the transition period, Lykos will work with a number of shareholders to secure financing for an additional Phase III ...
H1 entered a definitive agreement to acquire Ribbon Health on December 12th, 2024. Backed by notable investors including General Catalyst, Andreessen Horowitz (a16z), BoxGroup, Rock Health, and Sachin ...
H1 is strengthening its leadership team with the appointment of former FDA Commissioner Dr. Stephen M. Hahn to its board; announcing the strategic acquisition of Ribbon Health; and unveiling a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback